Capital generation remains constrained, evidenced by the bank's reliance on $12.7 million in investment securities sales during 2026Q1 to support liquidity needs amid suspended capital return programs.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|
| Cash from Operations | 32.25M | 5.42M | -6.31M | 44.06M | 93.93M | 59.21M | -108.34M | -20.58M | -4.57M | 45.66M | -2.11M | -5.82M | 2.27M | 14.21M | 2.39M |
| Operating CF Growth % | 867.69% | 185.94% | -114.32% | -53.1% | 58.63% | 154.65% | -426.36% | -350.49% | -110.01% | 2267.97% | 63.81% | -356.8% | -84.05% | 493.98% | - |
| Net Income | 11.98M | 10.71M | -15.38M | -51.77M | 17.33M | 52.48M | 17.7M | 4.6M | 4.57M | 3.35M | 688.73K | 2.5M | 2.03M | 1.84M | 1.52M |
| Depreciation & Amortization | 2.23M | 2.28M | 2.62M | 2.99M | 3.5M | 3.81M | 1.55M | 994K | 919.47K | 812.27K | 372.33K | 269.79K | 249.94K | 199.68K | 222.1K |
| Deferred Taxes | -2.22M | 1.24M | -6.19M | -7.05M | -20K | 1.92M | -1.68M | -85K | -9K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 3.21M | -6.81M | 37.15M | 93.46M | 67.46M | -431K | -111.56M | -25.59M | -6.88M | 38.99M | -3.34M | 608.69K | 310.11K | 1.13M | 653.02K |
| Working Capital Changes | 17.6M | -1.99M | -24.5M | 6.43M | 5.66M | 1.43M | -14.35M | -738K | -3.3M | 2.29M | -126.9K | -9.33M | -383.16K | 11.03M | 0 |
| Cash from Investing | 232.46M | 250.06M | 419.03M | -23.21M | -628.18M | 52.48M | -340.88M | -94.68M | -101.95M | -50.37M | -26.64M | -21.72M | -21.28M | -18.3M | -8.89M |
| Purchase of Investments | -43.09M | -36M | -18.22M | -5.13M | -79.57M | -276.51M | -45.07M | -71.91M | -16.54M | -15.44M | -5.23M | 0 | 0 | 0 | 0 |
| Sale/Maturity of Investments | 39.19M | 30.19M | 40.23M | 40.83M | 32.66M | 71.8M | 54.81M | 47.68M | 7.19M | 10.64M | 6M | 0 | 0 | 0 | 0 |
| Net Investment Activity | -3.9M | -5.81M | 22.01M | 35.7M | -46.92M | -204.71M | 9.74M | -24.24M | -9.35M | -4.8M | 766.89K | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 1.53M | 0 | 250K | 0 | 44.07M | 0 | -6.97M | 0 | 0 | -834.74K | 0 | 0 | 0 | 0 |
| Other Investing | 238.47M | 256.02M | 397.61M | -58.2M | -580.81M | 214.34M | -347.61M | -62.35M | -91.11M | -42.38M | -26.22M | -21.62M | -20.65M | -18.16M | -8.58M |
| Cash from Financing | -290.73M | -315.52M | -357.88M | 23.03M | 480.98M | -99.09M | 507.14M | 160.26M | 111.23M | 1.13M | 35.58M | 26.86M | 22.39M | 4.98M | 6.83M |
| Dividends Paid | -140K | -22.59M | 0 | -4.64M | -9.18M | -7.18M | -2.44M | -2.47M | -1.5M | -880.44K | -708.44K | -656.43K | -438.43K | -527.56K | -452.41K |
| Share Repurchases | -9.51M | -9.51M | 0 | 0 | 0 | 0 | -759K | 0 | 0 | 0 | 0 | 0 | 0 | -86.28K | 0 |
| Stock Issued | 313K | 9.76M | 152.14M | 103K | 87K | 804K | 759K | 22.12M | 128.77K | 53.53K | 0 | 0 | 0 | 0 | 0 |
| Net Stock Activity | -9.19M | 252K | 152.14M | 103K | 87K | 804K | 0 | 22.12M | 128.77K | 53.53K | 0 | 0 | 0 | -86.28K | 0 |
| Debt Issuance (Net) | -2M | -1000K | -1000K | -1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 0 |
| Other Financing | -256.4M | -268.18M | -450.02M | 64.32M | 188.37M | 325M | 504.38M | 88.92M | 75.59M | -1.54M | 46.48M | 9.45M | 20M | -384.67K | 7.28M |
| Net Change in Cash | -26.02M | -60.04M | 54.84M | 43.88M | -53.27M | 12.6M | 57.92M | 45M | 4.71M | -3.78M | 6.83M | -676.62K | 3.38M | 889.68K | 327.69K |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 115.95M | 175.99M | 121.15M | 77.27M | 130.55M | 117.94M | 60.03M | 15.03M | 10.32M | 14.1M | 7.27M | 7.94M | 4.56M | 3.67M | 3.34M |
| Cash at End | 146.61M | 115.95M | 175.99M | 121.15M | 77.27M | 130.55M | 117.94M | 60.03M | 15.03M | 10.32M | 14.1M | 7.27M | 7.94M | 4.56M | 3.67M |
| Interest Paid | 56.36M | 61.14M | 83.53M | 67.87M | 16.01M | 11.58M | 10.03M | 9.09M | 4.99M | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Taxes Paid | 4.82M | 6.58M | 0 | 6.66M | 2.08M | 10.13M | 2M | 1.02M | 1.35M | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 30.14M | 11.95M | -6.9M | 43.09M | 93.48M | 58M | -111.35M | -22.32M | -6.67M | 42.46M | -4.45M | -5.92M | 1.64M | 14.06M | 2.08M |
| FCF Growth % | 1125.07% | 273.18% | -116.01% | -53.9% | 61.18% | 152.08% | -398.81% | -234.93% | -115.7% | 1053.51% | 24.8% | -461.13% | -88.34% | 574.6% | - |
Regulatory consent order constraints
According to recent SEC filings, Blue Ridge Bankshares' ability to generate organic capital remains severely hampered, as evidenced by the volatile net income figures that swung from a $11.4 million loss in 2024Q2 to a modest $836,000 profit in 2026Q1, limiting internal capital accumulation capacity.
The bank's inconsistent profitability suggests that capital generation is currently insufficient to support meaningful balance sheet expansion. Investors should monitor whether the recent shift toward a back-to-basics strategy can stabilize earnings enough to rebuild the capital buffers eroded by previous aggressive growth and regulatory remediation costs.
As reported in financial statements, the bank has consistently utilized its investment securities portfolio as a liquidity source, with net sales frequently exceeding purchases, such as the $12.7 million in sales recorded in 2026Q1 compared to $11.3 million in purchases during the same period.
This pattern of active portfolio management appears to be a tactical response to funding pressures rather than a strategic investment shift. The reliance on securities sales to manage cash flow may indicate that the bank is prioritizing immediate liquidity needs over the long-term yield potential of its investment book.
Based on the provided cash flow data, Blue Ridge Bankshares has effectively halted meaningful capital returns to shareholders, with buybacks totaling only $6.7 million in 2025Q4 and negligible dividend activity, reflecting the severe capital constraints imposed by the ongoing OCC consent order and regulatory oversight.
The absence of a consistent dividend or buyback program underscores the bank's current focus on capital preservation and regulatory compliance. Any future resumption of capital returns appears unlikely until the bank demonstrates sustained profitability and satisfies the stringent capital adequacy requirements mandated by its primary regulators.
Data from recent quarterly reports shows significant fluctuations in provision expenses, including a $6.2 million charge in 2024Q3 followed by periods of reserve releases, which highlights the inherent credit risks embedded within the bank's specialized commercial and fintech-originated loan portfolios during this period of heightened regulatory oversight.
The inconsistency between provision levels and net income suggests that the bank is navigating a challenging credit environment where asset quality remains a primary concern. This volatility warrants further investigation into whether current reserve levels are sufficient to cover potential losses in the legacy BaaS-related loan segments.
Quick answers to the most common questions about buying BRBS stock.
Blue Ridge Bankshares, Inc. (BRBS) generated $5.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Blue Ridge Bankshares, Inc. (BRBS) generated $11.9M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Blue Ridge Bankshares, Inc. (BRBS) spent $1.7M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Blue Ridge Bankshares, Inc. (BRBS) returned $22.6M to shareholders via cash dividends and spent $9.5M on share repurchases. This shows the company's commitment to returning capital to its equity investors.